MUSTANG BIO, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Mustang Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2015 to Q4 2024.
  • Mustang Bio, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $65K, a 48% decline year-over-year.
  • Mustang Bio, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $493K.
  • Mustang Bio, Inc. annual Nonoperating Income (Expense) for 2024 was $493K.
  • Mustang Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.34M, a 71.4% decline from 2022.
  • Mustang Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.37M, a 487% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $65K -$60K -48% Dec 31, 2024 10-K 2025-03-28
Q3 2024 $47K -$202K -81.1% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $341K +$2.69M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $40K +$412K Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $125K +$327K Dec 31, 2023 10-K 2025-03-28
Q3 2023 $249K +$398K Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$2.34M -$1.49M -173% Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$372K -$215K -137% Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$202K -$272K -389% Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$149K -$221K -307% Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$858K -$939K -1159% Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$157K -$287K -221% Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $70K -$60K -46.2% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $72K +$2.6M Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $81K +$558K Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $130K +$467K Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $130K +$416K Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$2.53M -$2.35M -1368% Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$477K -$290K -155% Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$337K -$478K -339% Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$286K -$416K -320% Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$172K -$310K -225% Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$187K -$334K -227% Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $141K -$5K -3.43% Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $130K +$1K +0.78% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $138K -$6K -4.17% Sep 30, 2018 10-K 2020-03-16
Q2 2018 $147K +$11K +8.09% Jun 30, 2018 10-K 2020-03-16
Q1 2018 $146K +$58K +65.9% Mar 31, 2018 10-K 2020-03-16
Q4 2017 $129K +$1.05M Dec 31, 2017 10-K 2019-03-18
Q3 2017 $144K +$344K Sep 30, 2017 10-K 2019-03-18
Q2 2017 $136K +$229K Jun 30, 2017 10-K 2019-03-18
Q1 2017 $88K +$169K Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$917K -$849K -1249% Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$200K -$142K -245% Sep 30, 2016 10-K 2018-03-29
Q2 2016 -$93K -$51K -121% Jun 30, 2016 10-K 2018-03-29
Q1 2016 -$81K -$81K Mar 31, 2016 10-K 2018-03-29
Q4 2015 -$68K Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$58K Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$42K Jun 30, 2015 10-K 2017-03-31
Q1 2015 $0 Mar 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.